Caris Life Sciences vs Syantra

Caris Life Sciences vs Syantra, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Syantra on 53/100.

Caris Life Sciences logo
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Try Caris Life Sciences
Syantra logo
SyantraA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Try Syantra

Where each one leads

Caris Life Sciences

  • our overall score: 59/100 against 53/100
  • agent readiness: 47/100 against 38/100
  • headcount: 1,659 against 14
  • funding raised: $700M against $3.6M
  • LinkedIn following: 77,698 against 2,897

Syantra

Leads on none of the measures we hold for both companies.

At a glance

MeasureCaris Life SciencesSyantra
What it isCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
CategoryBiotech, MedTech, HealthTech, GenomicsBiotech, MedTech, HealthTech, Genomics
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20082016
HeadquartersIrving, United StatesCalgary, Canada
StatusActiveActive

Size, funding and growth

MeasureCaris Life SciencesSyantra
Employees1,65914
Total funding$700M$3.6M
Latest roundSeries DSeries A-1
Valuation$7.8BNot published
LinkedIn followers77,6982,897

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCaris Life SciencesSyantra
StartupHub scoreOur 0-100 rating59/10053/100
Traction60/10047/100
TeamNot published70/100
CommunityNot published15/100
Search visibility22/10023/100
Quality78/10058/100
Agent readinessHow well an AI agent can read and act on the siteD (47/100)F (38/100)
Domain ratingLink authority, 0-10062/100Not published

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCaris Life SciencesSyantra
HostingSelf ManagedNot detected
CMSWordPressNot detected
AnalyticsGoogle Tag ManagerNot detected

Caris Life Sciences vs Syantra: common questions

Which is better, Caris Life Sciences or Syantra?

On our 0-100 score Caris Life Sciences rates higher (59/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Caris Life Sciences and Syantra compare on the numbers?

Caris Life Sciences leads on our overall score (59/100 against 53/100), agent readiness (47/100 against 38/100), headcount (1,659 against 14), funding raised ($700M against $3.6M), LinkedIn following (77,698 against 2,897).

Read the full Caris Life Sciences review and pricing or the Syantra review and pricing. You can also browse other Caris Life Sciences alternatives we track.